New drug combo tested in fight against aggressive blood cancers
Disease control
Terminated
This early-stage study tested a new drug called DSP107, given alongside standard cancer drugs, for patients with hard-to-treat forms of leukemia and related blood disorders. The main goals were to find a safe dose and see if the combination could help control the disease. The stu…
Phase: PHASE1 • Sponsor: Kahr Medical • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC